We are live on ! Find out more
CPX

Canaan Partners X Portfolio holdings

AUM $74.7M
1-Year Est. Return 151.56%
This Fund
S&P 500
This Quarter Est. Return
+64.52%
1 Year Est. Return
+151.56%
3 Year Est. Return
+55.41%
5 Year Est. Return
10 Year Est. Return
AUM
$155M
AUM Growth
Cap. Flow
+$119M
Cap. Flow %
76.81%
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
NXTC icon
NextCure
NXTC
+$94.2M
2
IDYA icon
IDEAYA Biosciences
IDYA
+$19M
3
ITRM
Iterum Therapeutics
ITRM
+$5.64M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXTC icon
1
NextCure
NXTC
$20.8M
$127M 82.06%
+187,870
New +$94.2M
IDYA icon
2
IDEAYA Biosciences
IDYA
$3.54B
$20M 12.9%
+2,660,713
New +$19M
ITRM
3
DELISTED
Iterum Therapeutics
ITRM
$7.8M 5.04%
+115,545
New +$5.64M

Similar funds

Canaan Partners X's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Canaan Partners X, which disclosed 3 positions worth $155M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is NextCure: 187,870 shares worth $127M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Canaan Partners X's largest Q4 2019 buy was NextCure: 187,870 shares worth $127M.
  • Canaan Partners X's ten largest holdings make up 100% of its $155M portfolio in Q4 2019.
  • Canaan Partners X disclosed 3 positions in Q4 2019, its first 13F filing on record.

Based on Canaan Partners X's 13F filing for Q4 2019, filed 27 Jan 2020.